Skip to main content
Premium Trial:

Request an Annual Quote

3EO Health Licenses At-Home, Molecular Testing Technology from Wyss Institute

NEW YORK — 3EO Health signed an exclusive, worldwide licensing agreement to market an at-home PCR-grade assay system developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University, the partners announced on Thursday.

3EO Health Founder Peng Yin led the research that developed the technology at the Wyss Institute. Under the licensing agreement, his company will validate and eventually sell portable, rapid, and highly sensitive nucleic acid detection technology produced through that research.

The company plans to make a COVID-19 test the first commercially available product and the first step toward building a larger self-testing platform, which it predicts could improve the speed and effectiveness of self-care. In a statement, Yin said that existing at-home antigen tests lack sensitivity and molecular tests are expensive.

"We have developed a simple and rapid test platform that promises to deliver PCR-level accuracy at antigen level cost," he said.

Yin's research team at Wyss developed a reusable base unit that requires minimal user input and uses pathogen-specific single-use consumables.

"Subsequent work at 3EO Health fully integrated the assay and device components, improved the speed and signal output of the evolved assay method, and transformed the prototypes into an inexpensive, reliable, and manufacturable detection system," the partners said.

The company also announced plans to incorporate the detection platform into comprehensive telehealth applications.

Financial and other terms of the deal were not disclosed.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.